Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (569)	1/22/1998 3:11:00 PM
From: Scott	Read Replies (3) \| Respond to of 1686

PB, I just looked around on the web for posted policies on reimbursement by HMO's for off-label uses. The following is pretty typical, and is from a post by Blue Cross/Blue Shield. It seems to agree with my interpretation of Dr. Eddy's paper. Looking forward to your thoughts. Off-Label Drug Use FDA-approved drugs used for off-label indications will be provided only if recognized as effective for treatment 1) in one of the standard reference compendia; 2) in the majority of relevant peer-reviewed medical literature if not recognized in one of the standard reference compendia; 3) by the federal Secretary of Health and Human Services. No benefits will be provided for any drug when the FDA has determined its use to be contra-indicated. a."Off-label" means the prescribed use of a drug which is other than that stated in its FDA-approved labeling. b."Standard Reference Compendia" means: 1.The American Hospital Formulary Service-Drug Information; 2.The American Medical Association Drug Evaluation; 3.The United States Pharmacopoeia-Drug Information; 4.Other authoritative sources as identified by the Federal Secretary of Health and Human Services or the Insurance Commissioner. c."Peer-reviewed Medical Literature" means scientific studies printed in journals or other publications in which original manuscripts are published only after having been critically reviewed for scientific accuracy, validity, and reliability by unbiased independent experts. Peer-reviewed medical literature does not include in-house publications of pharmaceutical manufacturing companies.